Hyderabad-based Biological E Limited (BE), which recently launched its indigenously made Covid-19 vaccine Corbevax, will focus on new vaccines, specialty injectables, and branded generics.
The CDSCO approval has also been granted for two doses of ZyCov-D for those aged over 12. The decision comes amid a rise in Covid cases in cities like Delhi.
The jab will be supplied to the government at ₹145, helping the exchequer save ₹1,500 crore.
Covid-19 vaccines Corbevax and Covovax, and anti-viral medication Molnupiravir have been granted emergency use authorisation by the CDSCO.
The DCGI has given the nod for two vaccines and phase 1 of the vaccination process is expected to begin soon. Zydus Cadila’s vaccine candidate has also been cleared for phase 3 trials.
